| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962496 | Vaccine | 2016 | 5 Pages |
Abstract
This study, which is the first to report OBI in South African HCWs, found high rates of active HBV infection and sub-optimal protection against HBV in HCWs. There is a need to strengthen vaccination programmes through a policy that ensures protection for all HCWs and their patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Tsakani H. Sondlane, Lesego Mawela, Lufuno L. Razwiedani, Selokela G. Selabe, Ramokone L. Lebelo, J. Nare Rakgole, M. Jeffrey Mphahlele, Carine Dochez, Antoon De Schryver, Rosemary J. Burnett,